An update on the diagnosis and treatment of Parkinson disease

P Rizek, N Kumar, MS Jog - Cmaj, 2016 - Can Med Assoc
Methods We used Canadian and American national guidelines to inform this review, in
addition to published systematic reviews that were known to us. We identified additional …

Cardiac 123I-metaiodobenzylguanidine (MIBG) scintigraphy in Parkinson's disease: A comprehensive review

J Pitton Rissardo, AL Fornari Caprara - Brain Sciences, 2023 - mdpi.com
Cardiac sympathetic denervation, as documented on 123I-metaiodobenzylguanidine (MIBG)
myocardial scintigraphy, is relatively sensitive and specific for distinguishing Parkinson's …

[PDF][PDF] 2018 ESC Guidelines for the diagnosis and management of syncope

M Brignole, A Moya, FJ De Lange… - Polish Heart …, 2018 - journals.viamedica.pl
Pierwsze wytyczne ESC dotyczące postępowania w omdleniach opublikowano w 2001
roku, a ich kolejne wersje w latach 2004 i 2009. W marcu 2015 roku CPG uznała, że …

Cardiovascular/stroke risk stratification in Parkinson's disease patients using atherosclerosis pathway and artificial intelligence paradigm: a systematic review

JS Suri, S Paul, MA Maindarkar, A Puvvula, S Saxena… - Metabolites, 2022 - mdpi.com
Parkinson's disease (PD) is a severe, incurable, and costly condition leading to heart failure.
The link between PD and cardiovascular disease (CVD) is not available, leading to …

Clinical assessments in Parkinson's disease: scales and monitoring

R Bhidayasiri, P Martinez-Martin - International review of neurobiology, 2017 - Elsevier
Measurement of disease state is essential in both clinical practice and research in order to
assess the severity and progression of a patient's disease status, effect of treatment, and …

The search for a peripheral biopsy indicator of α-synuclein pathology for Parkinson disease

JM Lee, P Derkinderen, JH Kordower… - … of Neuropathology & …, 2017 - academic.oup.com
The neuropathological hallmark of Parkinson disease (PD) is abnormal accumulation of α-
synuclein (α-syn). Demonstrating pathological α-syn in live patients would be useful for …

Deep learning paradigm for cardiovascular disease/stroke risk stratification in Parkinson's disease affected by COVID-19: a narrative review

JS Suri, MA Maindarkar, S Paul, P Ahluwalia… - Diagnostics, 2022 - mdpi.com
Background and Motivation: Parkinson's disease (PD) is one of the most serious, non-
curable, and expensive to treat. Recently, machine learning (ML) has shown to be able to …

Identification of genetic factors that modify motor performance and body weight using Collaborative Cross mice

JH Mao, SA Langley, Y Huang, M Hang… - Scientific reports, 2015 - nature.com
Evidence has emerged that suggests a link between motor deficits, obesity and many
neurological disorders. However, the contributing genetic risk factors are poorly understood …

Chaudhuri's Dashboard of Vitals in Parkinson's syndrome: an unmet need underpinned by real life clinical tests

MA Qamar, S Rota, L Batzu, I Subramanian… - Frontiers in …, 2023 - frontiersin.org
We have recently published the notion of the “vitals” of Parkinson's, a conglomeration of
signs and symptoms, largely nonmotor, that must not be missed and yet often not considered …

High cervical spinal cord stimulation: a one year follow-up study on motor and non-motor functions in Parkinson's disease

P Mazzone, F Viselli, S Ferraina, M Giamundo… - Brain Sciences, 2019 - mdpi.com
Background: The present study investigated the effectiveness of stimulation applied at
cervical levels on pain and Parkinson's disease (PD) symptoms using either tonic or burst …